Bitcoin price hit a resistance near $87,220 before retreating to around $84,575, driven by whale investors selling over 30,000 BTC, worth about $2.52 billion. This selling pressure shifted attention to the $82,500 support zone, reinforced by technical indicators like the lower Bollinger Band and liquidation clusters near $82,000-$82,800. However, a sustained rebound depends on renewed whale accumulation at this level. Additionally, Bitcoin faces selling pressure near $89,000, where many investors who bought 6-12 months ago have their cost basis, indicating overhead supply that could limit upside gains. The market awaits confirmation that support holds and whale buying resumes to signal a potential recovery.
Bitcoin whale activity is the subject, with Pluang market data as context for readers. As of Oct 03, 2026 20:21 WIB, among 50 major cryptocurrencies priced on Pluang, 11 rose and 38 fell. Notable movers include EOS up 8.13% at Rp12.649 with a typical hold time of 87 days, Enjin Coin down 7.38% at Rp607 with 100% sell order activity, and PancakeSwap down 5.50% at Rp44.374 with 63% buy order activity. EOS's 8.13% gain stands out as the most notable figure.
DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...
SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...
Jupiter (JUP) trades at $0.263, about 30% below its 12-month high and 92% above its low. The recent price correction stopped near the 200-day moving average at $0.242, a critical support level that buyers defended twice. For a trend reversal, JUP mus...
Bitcoin recently fell 4.4% below its 200-week moving average, a rare event that coincides with a Fear and Greed Index reading of 10, signaling extreme market fear. Michael Saylor highlighted these metrics but did not link them directly to the price d...
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...
